The Supreme Court unanimously rejected a bid to restrict access to mifepristone, part of a two-drug regimen used to induce medical abortions.
The high court concluded a group of anti-abortion doctors that brought the case forward lacked standing to challenge the Food and Drug Administration’s prior regulatory approval of the pill.
“The plaintiffs have sincere legal, moral, ideological, and policy objections to elective abortion and to FDA’s relaxed regulation of mifepristone. But under Article III of the Constitution, those kinds of objections alone do not establish a justiciable case or controversy in federal court,” Justice Brett Kavanaugh wrote in the opinion.
